Exploring the Factors to Regulate Sweating by Transcriptome Analysis for Anhidrosis: Novel Role of Olfactory Receptors on Sweating via Exposing to Beta-Ionone

    N. Murayama, T. Miyaki, H. Hayashi, Y. Tanaka, H. Murota
    Image of study
    TLDR Sweating can potentially be controlled through olfactory receptors, with β-ionone playing a key role, and responses may vary between genders.
    The study conducted by N. Murayama, T. Miyaki, and H. Murota from Nagasaki University Graduate School of Biomedical Sciences and Sasebo City General Hospital, Japan, aimed to understand the pathogenesis of Acquired Idiopathic Generalized Anhidrosis (AIGA), a disease that impairs sweat production and can lead to fatal heatstroke and skin dryness. Using transcriptome analysis, they compared skin samples from anhidrotic (non-sweating) and hidrotic (sweating) areas of patients. They found that the expression of olfactory receptor genes was up-regulated in hidrotic sweat glands and down-regulated in anhidrotic sweat glands. Specifically, they confirmed the expression of OR51A7 and OR51E2 in human eccrine sweat glands. They also discovered that β-ionone activates G proteins through OR51A7 or OR51E2, and the responses to β-ionone differed between genders. These findings suggest the possibility of regulating sweating activity via olfactory receptors.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 63 results

      community Atherosclerosis as cause of balding and treatment

      in Treatment  61 upvotes 1 year ago
      Hair loss may be caused by calcification of capillaries in the scalp, restricting blood flow to hair follicles. A daily treatment regimen including high doses of Vitamins D and K, Magnesium, and Nattokinase could potentially decalcify these capillaries, improving blood flow and hair growth. However, some users warn against excessive Vitamin D intake and emphasize the need for medical consultation.
      The story of RU58841/ PSK3841

      community The story of RU58841/ PSK3841

      in Research  622 upvotes 6 months ago
      RU58841, a potential hair loss treatment, was not commercialized due to marketability issues and lack of long-term safety data. Concerns about its formulation and delivery methods further complicate its use.

    Similar Research

    5 / 1000+ results